Leslie Tari - 12 Jan 2023 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role
CHIEF SCIENTIFIC OFFICER
Signature
/s/ Shane Ward, Attorney-in-Fact
Issuer symbol
CDTX
Transactions as of
12 Jan 2023
Net transactions value
-$14,177
Form type
4
Filing time
27 Jan 2023, 15:33:47 UTC
Previous filing
13 Sep 2022
Next filing
13 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDTX Common Stock Sale $14,177 -11,814 -89% $1.20 1,484 12 Jan 2023 By spouse
holding CDTX Common Stock 197,741 12 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 4,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan ("ESPP") on November 18, 2022.